To investigate the epigenetic modulation of GCNT2 in AML, we correlated the GCNT2 RNA-seq date with each of the 34 CpG sites methylations using the SMART, of note, 16 out of the 34 CpG sites showed significant negative correlation coefficients, still, the aggregation of the averaged methylation of the 34 CpG sites also demonstrated a remarkable negative correlation with GCNT2 expression (r = -042, P = 1.8 e-08), (Figure 6A). This evidence concerns the gene GCNT2 and acute myeloid leukemia.